Your browser doesn't support javascript.
loading
The effects of Sorafenib and Natural killer cell co-injection in combinational treatment of hepatocellular carcinoma; an in vivo approach.
Hosseinzadeh, Faezeh; Ai, Jafar; Hajifathali, Abbas; Muhammadnejad, Samad; Ebrahimi-Barough, Somayeh; Seyhoun, Iman; Komeili Movahed, Tahereh; Shirian, Sadegh; Hosseinzadeh, Fatemeh; Ahmadpour, Sajjad; Alijani, Mohammadreza; Verdi, Javad.
Afiliação
  • Hosseinzadeh F; Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. f.hosseinzadeh@muq.ac.ir.
  • Ai J; Department of Tissue Engineering, Qom University of Medical Sciences, Qom, Iran. f.hosseinzadeh@muq.ac.ir.
  • Hajifathali A; Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran. f.hosseinzadeh@muq.ac.ir.
  • Muhammadnejad S; Department of Tissue Engineering, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Ebrahimi-Barough S; Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Seyhoun I; Gene Therapy Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Komeili Movahed T; Department of Tissue Engineering, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Shirian S; Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Hosseinzadeh F; Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran.
  • Ahmadpour S; Department of Pathology, School of Veterinary Medicine, Shahrekord University, Shahrekord, Iran.
  • Alijani M; Shiraz Molecular Pathology Research Center, Dr. Daneshbod Path Lab, Shiraz, Iran.
  • Verdi J; Dentistry Faculty, Tehran University of Medical Sciences, Tehran, Iran.
Pharmacol Rep ; 74(2): 379-391, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35089543

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article